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Abstract
Background: The medical community has been deeply involved in fighting the Coronavirus disease 2019 (COVID-
19) pandemic and, as a consequence, the care of non-COVID-19 patients has been impacted. However, the
treatment of head and neck cancer patients is not deferrable, and an integrated strategy is required. The aim of the
current article is to present the experience in the management of head and neck patients during the COVID-19
pandemic at the research hospital “Casa Sollievo della Sofferenza”. This review contains replicable and widely usable
instructions on how to avoid delays in the diagnosis and treatment of head and neck tumors and to ensure a
gradual return to elective procedures.
Main text: The Head and Neck Department of the research hospital “Casa Sollievo della Sofferenza” includes an
Otolaryngology and a Maxillofacial Surgery Unit, both of which deal with the diagnosis and treatment of benign
and malignant pathologies of the head and neck, as well as urgent/emergent consultations and surgical
procedures that necessitate time sensitive operative management, such as cochlear implantation (CI). Given these
premises and the complexity of the Department, the “COVID-19 organizing protocol” of the research hospital “Casa
Sollievo della Sofferenza” was divided into two phases in accordance with the different stages of the pandemic and
the priority of treatment. Special attention was given to the medical surveillance of health care workers and
hospitalized patients, to the organization of the outpatient clinic and the operating setting as well as to the
implementation of telehealth systems.
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Conclusions: The COVID-19 pandemic is going to be a long-term situation with lasting effects on the public health
and the entire society. Therefore, an efficient health care system has to adopt a double strategy: always being ready
for a “new wave” of the pandemic and not forgetting non-COVID-19 patients, among whom head and neck cancer
patients represent a priority. More than 1 year since the first outbreak in Wuhan, this review offers a unique and
helpful perspective that incorporates awareness of the disease.
Keywords: Coronavirus disease, Critical care, Hospital administration, Ambulatory care, Primary health care,
Otolaryngology, Maxillofacial surgery, Head and neck cancer, Infection
Introduction
Coronavirus Disease 2019 (COVID-19) is a global pan-
demic caused by the novel severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) infection, which is
responsible for a wide range of mild to severe symptoms
of the respiratory tract and multiple organ systems. In
its most severe forms, the treatment of COVID-19 in-
volves a multi-specialist approach and an integrated
strategy [1]. Since the first cases in December 2019 in
Wuhan, China, the medical community has been deeply
involved in fighting this unprecedented pandemic and,
as a consequence, the management of non-COVID-19
patients has been profoundly impacted. A survey con-
ducted by the Italian Society of Otolaryngology-Head
and Neck Surgery (SIOeChCF) reported a decrease in
the number of elective otolaryngology (ORL) activities
by 81.24% and a conversion of the Italian ORL depart-
ments in COVID-19 units in 22% of cases [2], while an-
other study evidenced a reduction in the number of
ORL emergency consultations by 80.8% [3]. Although
the treatment of many Ear, Nose and Throat (ENT) con-
ditions could be deferrable without any consequences,
this is not the case in head and neck cancer patients
whose care has to be prioritized during these difficult
times [4]. Besides maintaining high-quality standards of
treatment, the other main priority of regional cancer
hubs has been the prevention of COVID-19 nosocomial
infections. In addition to guaranteeing patients’ safety,
the protection of physicians and health professionals
plays a role of primary importance in limiting the spread
of the disease [5]. Otolaryngology-head and neck surgery
(ORL-HNS) has been recognized as one of the special-
ties at highest risk since March 2020 [6] due to the
symptoms of upper respiratory tract infections (URTI)
which can be similar to the manifestations of COVID-19
(i.e. smell and taste dysfunction [7, 8], dysphonia [9])
and to the invasive nature of examinations (i.e. nasal en-
doscopy) and aerosol-generating procedures (AGPs) (i.e.
functional endoscopic sinus surgery [10], tracheostomy
[11], mastoidectomy [12], orthognathic surgery [13]).
The international registry of Otolaryngologists-head and
neck surgeons promoted by the Young Otolaryngolo-
gists–International Federation of Otolaryngologic
Societies (YO-IFOS) has identified 361 Otolaryngologists
reporting COVID-19 at the time of publication in May
2020 and, unfortunately, this number has increased
worldwide during the last months [14]. Another multi-
centric survey conducted in 23 Italian maxillofacial
surgery departments found that 4% of maxillofacial sur-
geons and 22% of maxillofacial surgery residents tested
positive for COVID-19 [15].
Given these premises, we would like to present our ex-
perience in the management of head and neck patients
during the COVID-19 pandemic at the research hospital
“Casa Sollievo della Sofferenza”, which has been recog-
nized as the best hospital of Southern Italy, according to
the annual Newsweek report [16] and is located in one
of the hardest hit provinces of the Puglia region. The
main purpose of this review is to provide replicable and
widely usable recommendations in order to avoid delays
in the diagnosis and treatment of head and neck tumors,
which can be life changing for the patients both in terms
of mortality and quality of life, while ensuring a gradual
return to elective procedures.
The “COVID-19 organization protocol” at the
research hospital “Casa Sollievo della Sofferenza”
The “COVID-19 organization protocol” at the research
hospital “Casa Sollievo della Sofferenza” was created in
cooperation with the Preventive Medicine and Hygiene
Section of the Institution and in accordance with the
guidelines from the Higher Institute of Health (ISS).
The Head and Neck Department includes an Oto-
laryngology and a Maxillofacial Surgery Unit, both of
which deal with the diagnosis and treatment of benign
and malignant pathologies of the head and neck, such as
benign and malignant tumors of the salivary glands, the
oral cavity, the skin, the larynx, the paranasal sinuses
and anterior skull base. Free flap surgery is executed by
the Maxillofacial Surgeons for the reconstruction of
complex head and neck defects and facial reanimation.
The anterolateral thigh and radial forearm free flaps are
the most commonly performed procedures at our insti-
tution, 50 and 49 flaps on average per year, respectively
according to a recent case review [17]. Additionally, the
Head and Neck Department performs urgent/emergent
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consultations (i.e., maxillofacial traumas, vertigo, inflam-
matory diseases, foreign bodies, airway obstructions,
sudden hearing loss, epistaxis, etc.), which requires a
high priority level within the hospital administration. Be-
sides the ORL emergencies and cancer patients, the
Head and Neck Department is also a referral center for
other surgical procedures, such as cochlear implantation
(CI), that necessitate time sensitive operative manage-
ment [18]. Given these premises and the complexity of
the organization, an integrated strategy was requested in
order to provide adequate treatment to every patient
within an appropriate timeframe.
Medical surveillance of health care workers and
hospitalized patients during the COVID-19 pandemic
The safety of health care workers plays a central role in
guaranteeing the best possible treatments to patients.
The Head and Neck Department currently employs one
Director, 10 otolaryngologists, 6 maxillofacial surgeons,
3 resident physicians, 22 registered nurses, 4 speech
therapists, 3 audiometric technicians, 10 healthcare
operators and one health coordinator. The hospital
requires health care workers to undergo nasal/oropha-
ryngeal swabs for the detection of COVID-19 every
month, in case of suspicion/contact with positive indi-
viduals, and for those returning after travelling out-
side the Puglia region. Specifically, molecular tests are
the first choice at our hospital for the diagnosis of
SARS-CoV-2 infection and the procedure comprises
the execution of a double nasal/oropharyngeal swab.
The nasal/oropharyngeal swabs are routinely per-
formed by the otolaryngologists on patients/healthcare
workers, and otolaryngologists are subjected to swabs
for diagnosis, as well. The support of the ENT team
is fundamental for minimizing the false negative rate
among COVID-19 positive individuals [19].
Patients admitted to the Head and Neck Department
have to test negative for COVID-19 in order to be hospi-
talized or must undergo a swab test, if referred for emer-
gency ORL consultations by the Emergency Department.
Patient visitors are routinely not allowed in the Depart-
ment; exemptions are granted upon request for valid
reasons. In case of undeferrable ENT conditions, such as
dyspnea, hemorrhage, which require immediate treat-
ment, without the possibility to perform a swab test,
patients are considered positive and temporarily hospi-
talized in a distinct “COVID-19 gray area”. This area has
a dedicated patient room/operating room with separate
entrances and negative pressures where suspected pa-
tients can receive the appropriate treatment and/or
undergo the life-saving surgical procedure while waiting
for the response of molecular test (usually 3–6 h). In
such cases, the health care personnel wear personal pro-
tective equipment (PPE) indicated by the guidelines of
the SIOeChCF for tracheostomies [20]/surgical activities
[21] which consists of FFP2 or preferably FFP3 mask,
face shield, double gown, double gloves, double cap and
shoe cover. This was the recent case of a patient (male;
53 years old) affected by a laryngeal malignant tumor
classified as IVA according to American Joint Commit-
tee on Cancer (AJCC) Cancer Staging Manual (8th
Edition), who firstly underwent a tracheostomy in the
“COVID-19 gray operating room” and was subsequently
hospitalized in the Head and Neck Department after
testing negative. Two days after the tracheostomy, he
could safely undergo a total laryngectomy with bilateral
cervical lymphadenectomy without any delay in diagno-
sis and treatment.
Also, it is worth noting that head and neck cancer
patients warrant additional surveillance during the
COVID-19 pandemic as they are particularly susceptible
to pulmonary infections and respiratory complications
[22]. This was the recent case of a patient (male; 50 years
old) hospitalized in the Head and Neck Department who
underwent an open partial horizontal laryngectomy
(OPHL) type IIa and developed post-operative pneumo-
nia documented by computed tomography (CT). After
excluding bacterial and fungal etiologies, a high level of
suspicion for SARS-CoV-2 infection was raised and the
patient was isolated while undergoing several tests in
cooperation with the Internal Medicine Department.
Besides blood tests for the differential diagnosis (i.e.,
Cytomegalovirus, Epstein-Barr virus), the patient under-
went two other swab tests and serology testing for
COVID-19 after 1 week, all of which were negative.
Bronchoalveolar lavage (BAL) was performed to defini-
tively exclude COVID-19 and the patient was able to
stop isolation without any risks to the other patients and
health workers.
Three registered nurses and one Otolaryngologist
tested positive for COVID-19 thus far, while no hospital-
ized patients with COVID-19 have been identified.
Therefore, it is possible that the health care workers
who tested positive contracted the disease outside the
hospital or in a location other than the Head and Neck
Department. Certainly, this vigilant medical surveillance
limited the spread of the disease and the occurrence of
an outbreak so that even during the Italian lockdown,
interruption to the activities of the Head and Neck De-
partment or its conversion in COVID-19 unit, was never
required.
Guide to provide care during the COVID-19 pandemic
The “COVID-19 organizing protocol” at the research
hospital “Casa Sollievo della Sofferenza” was divided into
two phases in accordance with the different stages of the
pandemic and the priority of treatment:
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 Phase 1 protocol (carried out from March 2020 to
May 2020): The Head and Neck Department was
active only for urgent/emergent surgical procedures
and consultations, as well as for the management of
undeferrable oncologic patients, including those
scheduled for reconstructive procedures.
 Phase 2 protocol (from June 2020 to present): The
Head and Neck department is gradually returning to
the clinical and surgical routine of the pre-COVID-
19 era. Besides the procedures and consultations in-
cluded in the “phase 1 protocol”, the surgical proce-
dures scheduled in this phase include at least one CI
per week, as well as tympanomastoidectomy for
chronic ear disease/cholesteatoma prioritizing cases
with imminent complications, removal of benign tu-
mors of head and neck, orthodontic-orthognathic
surgery in disabled patients, functional endoscopic
sinus surgery (FESS) including dacryocystorhinost-
omy (DCR) for inflammatory disease priority cases
with impending complications, sleep surgery includ-
ing transoral robotic surgery (TORS) priority pa-
tients affected by severe obstructive sleep apnea
syndrome (OSAS) patients (apnea hypopnea index,
AHI: > 30). Table 1 demonstrates the changes of
head and neck pathologies presented by hospitalized
patients at our department before and during the
COVID-19 pandemic.
Additionally, the Head and Neck team designated two
maxillofacial surgeons and two otolaryngologists to be in
charge of consultations for the hospitalized COVID-19
patients, as well as for the tracheostomies in COVID-19
patients in the intensive care unit (ICU). Tracheostomies
have been performed by the Head and Neck team in 23
COVID-19 patients thus far. However, according to the
call to action from the European Laryngological Societies
[23], the recommendation of our institution was to delay
tracheostomy until the patient no longer requires venti-
lation in the prone position. Therefore, the main indica-
tion for tracheostomy was limited to COVID-19 patients
with prolonged endotracheal intubation lasting more
than 14–21 days. Patients discharged from the ICU are
then scheduled for a strict ORL follow-up in cooperation
with the Laryngologist in our department to monitor the
potential occurrence of laryngotracheal complications
(i.e., stenosis, granulomas, etc.).
Lastly, the pre-COVID-19 number of hospital beds
was 34 and has been reduced by 50% during the pan-
demic. Therefore, the current number of beds in the
Head and Neck Department is 16 plus one bed available
for urgencies/emergencies. No more than one patient in
a double room and two patients in a quadruple room
are being hospitalized in phase 1 and 2 in order to guar-
antee adequate distance between individuals. One empty
bed is left between one patient and another whenever







Adenoid hypertrophy/adenotonsillar hypertrophy 108 4 −96.3%
Airways obstruction (dyspnea) 63 53 −15.9%
Benign tumors of head and neck 64 39 −39.1%
Congenital cysts and fistulas of the neck 4 0 −100%
Diseases of the paranasal sinuses and tympanomastoid cavity requiring surgery 116 32 −72.4%
Dentofacial deformity 66 31 −53.0%
Epistaxis 16 8 −50.0%
Pharyngotonsillitis/ peritonsillar abscess 23 11 − 52.2%
Malignant neoplasms of the head and neck 58 56 −3.7%
Maxillofacial trauma 71 38 −46.5%
Miscellanea 373 170 −54.4%
Nasal bone fractures 36 12 − 66.7%
Nasal deformities/septal deviation 33 0 −100%
Otitis media 27 7 −74.1%
Otitis media with effusion
(ear tube insertion)
17 0 −100%
Vertigo 45 8 −82.2%
aPre-COVID-19 Time: March 1st to November 30th, 2019
bCOVID-19 Time: March 1st to November 30th, 2020
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possible or at least 2 m of space between beds. As an
additional safe distancing measurement, patients’ beds
are placed diagonally [24].
Organization of the outpatient clinic
During the Italian lock-down, which limited people’s
movement and coincided with the “phase 1 protocol”,
the role of the telephone triage was fundamental. Dedi-
cated personnel were in charge of ascertaining the ab-
sence of signs/symptoms of COVID-19 and establishing
the urgency/priority of the visit. With the “phase 2
protocol”, the activities of the outpatient clinic gradually
returned back to the ordinary routine and patients on
the waiting list were recalled. Twenty outpatients per
day (Monday-Friday) were usually scheduled before the
COVID-19 pandemic. The number of visits was reduced
to 6 during the “phase 1 protocol” and almost returned
to normal during the “phase 2 protocol” with 18 outpa-
tients visited per day. Plexiglass protective barriers have
been installed in order to prevent the spread of respira-
tory droplets and protect patients and personnel. Ac-
cording to the type and complexity of the visit, a waiting
time ranging from 20 to 40 min is guaranteed between
one patient and another in order to sanitize and aerate
the room.
In accordance with the guidelines of the SIOeChCF
[25], the health care workers admitted to the outpatient
clinic should be limited to the essential (a nurse, an at-
tending and a resident). The temperature check is done
immediately upon arrival. Only the patient is admitted
to the visit; visitors are not allowed, except for children
and patients with disabilities. Physician and patient
should maintain one-meter-distance in between each
other during the interview. Empty seats should be left in
the waiting room in order to ensure social distancing.
Both health care professionals and the patient should
wash and / or sanitize their hands before the visit starts.
Personnel should wear a disposable water-repellent
gown, face shield, FFP2 or preferably FFP3 mask, cap
and non-sterile gloves. During the visit it is important
that the patient wears a surgical mask that should only
be removed when necessary.
Organization of the operating setting
According to the guidelines of the SIOeChCF [21], pa-
tients have to undergo a swab test for the detection of
SARS-CoV-2 infection within 48 h before surgery.
When, for any reason, it is not possible to execute a
swab test, the patient should be considered positive for
COVID-19. When patients test negative, high-level PPE
are not required, while in cases of positive or suspected
patients, the personnel should be limited to the essential
and wear double gowns, double gloves, shoe cover,
double cap, FFP2 or possibly FFP3 mask covered by a
surgical mask and face shield.
Negative pressures in the operating rooms are funda-
mental in limiting the diffusion of pathogens, including
SARS-CoV-2.
The use of debriders, drills, powered instruments and
electrocoagulation should be limited or avoided. When
this is not possible, the use of high-level PPE together
with COVID-19 patient screening is strongly recom-
mended [26]. The same PPE are warranted for the team
executing tracheostomies in COVID-19 patients. Further
precautions are trying not to puncture the cuff of the
tracheostomy tube and preferring cuffed non-fenestrated
tubes.
Moreover, especially during these critical times, it is
important for head and neck surgeons to work in co-
operation with the ICU and check the availability of beds
before performing any complex surgical procedures (i.e.,
TORS, free flap surgery, laryngectomy).
Toward the health system of the future: implementing
telehealth systems in the COVID-19 era
In the last few years telehealth systems have become in-
creasingly important and more and more sophisticated;
likely, telehealth consultations are going to become or-
dinary in medicine in the near future and patients will
be increasingly followed virtually. This implementation
will help reduce the costs and inconvenience of travel-
ling and clinics will be able to receive external technical
support very quickly. Additionally, physicians and thera-
pists will be able to provide care remotely and guarantee
access to high-level services even to underserved and
rural areas [27].
In the era of “social distancing”, the potentialities of
eHealth and telemedicine appear even more promising
and our institution is also taking advantage of these sys-
tems. In fact, during the “phase 1 protocol”, the CI team
in the Head and Neck Department performed the first
“remote fitting” [28] of a CI system. The implanted pa-
tient was a woman living outside of the Puglia region
who underwent CI surgery in March 2020, prior to the
Italian lockdown. Activation, mapping and measure-
ments were performed by the CI team during a tele-
health session preventing the patient from having to
travel a distance during the critical phase of lockdown.
In-person visits gradually started to be scheduled again
with the activation of “phase 2 protocol”, but the” re-
mote fitting” system was successfully tested and is ready
for an eventual return to the “phase 1 protocol”.
Additionally, telehealth consultations played a central
role in the management of head and neck cancer pa-
tients. The Department supported a campaign promoted
by the Italian Association of Head and Neck Oncology
(AIOCC) [29] to raise awareness for head and neck
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cancer tumors. Patients were invited to fill out an online
questionnaire and subjects at risk were automatically
scheduled for a free telehealth consultation and/or an
in-person visit.
Discussion and conclusions
The fear of this “new COVID-19 era” should not deter-
mine a “new cancer era”. Head and neck surgeons know
how crucial early diagnosis is in oncological patients, as
it implies higher probability of treatment success. There-
fore, when counseling head and neck cancer patients,
the take home message of this first year of the COVID-
19 pandemic should be “the sooner, the better”. From
our experience, one of the greatest difficulties was the
cancer screening, as patients tend to seek medical atten-
tion at a more advanced disease stage or when they have
already developed life-threatening complications. In our
opinion, the fear of acquiring a nosocomial COVID-19
infection together with the inappropriate organization of
many hospitals played a central role in this delay. Con-
versely, the oncological patients already scheduled for
surgical operations experienced a shorter waiting time
than the pre-COVID-19 era due to the cancellation/re-
duction of elective procedures [30].
One year since the first outbreak in Wuhan, China, we
now have a clear understanding that the COVID-19 pan-
demic is going to be a long-term situation with lasting
effects on public health and the entire society [31].
Therefore, an efficient health care system has to adopt a
double strategy in this historical moment: always being
ready for a surge of COVID-19 cases, while not forget-
ting non-COVID-19 patients, among whom, head and
neck cancer patients represent a priority. Distinct from
the articles [32] and guidelines [33] published during the
first months of the pandemic, this review presenting the
“COVID-19 organization protocol” of the research hos-
pital “Casa Sollievo della Sofferenza” offers a different
and enduring perspective accompanied by a new aware-
ness of the disease and a gradual return to elective pro-
cedures. The COVID-19 pandemic has undoubtedly
only accelerated the process toward the health care sys-
tem of the future, where telemedicine [34], artificial
intelligence [35] and mobile applications [36] are going
to have more and more use.
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